大主宰天蚕土豆,完美世界前传下载

表皮生長(zhǎng)因子受體(EGFR)真核蛋白

Eukaryotic Epidermal Growth Factor Receptor (EGFR)

ErbB-1; ErbB1; ER1; ERB-B1; MENA; HER1; Erythroblastic Leukemia Viral(v-Erb-B)oncogene Homolog,Avian; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1

編號(hào)EPA757Hu62
物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 所有
- 人
- 小鼠
- 大鼠
- 豚鼠
- 家兔
- 獼猴
- 山羊
- 綿羊
- 馬
- 牛
- 豬
- 雞
- 狗
- 其他物種
- 多物種
- 泛物種
來(lái)源真核表達(dá)
宿主293F cell
內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
亞細(xì)胞定位分泌
預(yù)測(cè)分子量70.2kDa
實(shí)際分子量120kDa(差異分析請(qǐng)參閱說明書)
片段與標(biāo)簽Leu25~Ser645 with N-terminal His Tag
緩沖液成份PBS, pH7.4, containing 5% Trehalose.
性狀凍干粉
純度> 90%
等電點(diǎn)6.5
應(yīng)用 Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見活性蛋白。
下載英文說明書中文說明書
規(guī)格 10μg50μg 200μg 1mg 5mg
價(jià)格 ¥ 972 2430 ¥ 2430 ¥ 4860 ¥ 14580 ¥ 36450
欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!

產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)

Figure . Gene Sequencing (extract)

Figure. SDS-PAGE

通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

序列

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲(chǔ)存

避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。

贈(zèng)品

聚丙烯酰胺凝膠電泳(PAGE)實(shí)驗(yàn)服務(wù)

增值服務(wù)

BCA蛋白定量檢測(cè)試劑盒
 蛋白標(biāo)記定制服務(wù)
蛋白分子量MARKER
單克隆抗體定制服務(wù)
多克隆抗體定制服務(wù)
蛋白活性測(cè)定實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
電泳遷移率變動(dòng)分析(EMSA)實(shí)驗(yàn)服務(wù)
緩沖液
 慢病毒包裝實(shí)驗(yàn)服務(wù)
腺病毒包裝實(shí)驗(yàn)服務(wù)
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
棘突蛋白受體結(jié)合結(jié)構(gòu)域
 蛋白G
蛋白 A

相關(guān)產(chǎn)品

編號(hào)	適用物種：Homo sapiens (Human，人)	應(yīng)用(僅供研究使用，不用于臨床診斷！)
APA757Hu01	表皮生長(zhǎng)因子受體(EGFR)活性蛋白	Cell?culture;?Activity?Assays.
APA757Hu02	表皮生長(zhǎng)因子受體(EGFR)活性蛋白	Cell?culture;?Activity?Assays.
APA757Hu62	表皮生長(zhǎng)因子受體(EGFR)活性蛋白	Cell?culture;?Activity?Assays.
RPA757Hu01	表皮生長(zhǎng)因子受體(EGFR)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
APA757Hu61	表皮生長(zhǎng)因子受體(EGFR)活性蛋白	Cell?culture;?Activity?Assays.
EPA757Hu62	表皮生長(zhǎng)因子受體(EGFR)真核蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
RPA757Hu02	表皮生長(zhǎng)因子受體(EGFR)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
EPA757Hu61	表皮生長(zhǎng)因子受體(EGFR)真核蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
PAA757Hu06	表皮生長(zhǎng)因子受體(EGFR)多克隆抗體	WB; IHC; ICC; IP.
PAA757Hu02	表皮生長(zhǎng)因子受體(EGFR)多克隆抗體	WB; IHC; ICC; IP.
PAA757Hu01	表皮生長(zhǎng)因子受體(EGFR)多克隆抗體	WB; IHC; ICC; IP.
FAA757Hu51	抗表皮生長(zhǎng)因子受體(EGFR)多克隆抗體(別藻藍(lán)蛋白標(biāo)記)	FCM
MAA757Hu27	表皮生長(zhǎng)因子受體(EGFR)單克隆抗體	WB; IHC; ICC; IP.
MAA757Hu29	表皮生長(zhǎng)因子受體(EGFR)單克隆抗體	WB; IHC; ICC; IP.
RAA757Hu21	表皮生長(zhǎng)因子受體(EGFR)重組抗體	WB; IF; ICC; IHC; IP; FCM.
MAA757Hu21	表皮生長(zhǎng)因子受體(EGFR)單克隆抗體	WB; IHC; ICC; IP.
MAA757Hu23	表皮生長(zhǎng)因子受體(EGFR)單克隆抗體	WB; IHC; ICC; IP.
MAA757Hu24	表皮生長(zhǎng)因子受體(EGFR)單克隆抗體	WB; IHC; ICC; IP.
MAA757Hu25	表皮生長(zhǎng)因子受體(EGFR)單克隆抗體	WB; IHC; ICC; IP.
MAA757Hu22	表皮生長(zhǎng)因子受體(EGFR)單克隆抗體	WB; IHC
SEA757Hu	表皮生長(zhǎng)因子受體(EGFR)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)	Enzyme-linked immunosorbent assay for Antigen Detection.
HEA757Hu	表皮生長(zhǎng)因子受體(EGFR)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)	Enzyme-linked immunosorbent assay for Antigen Detection.
AEA757Hu	抗表皮生長(zhǎng)因子受體抗體(Anti-EGFR)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)	Enzyme-linked immunosorbent assay for Antibody Detection.
LMA757Hu	表皮生長(zhǎng)因子受體(EGFR)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)	FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志	參考文獻(xiàn)
Thoracic Cancer	Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer [Wiley: source]
J Cent Nerv Syst Dis.?	Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism … [Pubmed:25249767]
Mol Cancer Ther	GC1118, an anti-EGFR antibody with a distinct binding epitope and superior inhibitory activity against high-affinity EGFR ligands [PubMed: 26586721]
Cell Death Dis.?	LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway [Pubmed:26938303]
analytica chimica acta	Microfluidic immunosensor based on mesoporous silica platform and CMK-3/poly-acrylamide-co-methacrylate of dihydrolipoic acid modified gold electrode for cancer biomarker detection. [pubmed:28335979]
Talanta	EGFR detection in extracellular vesicles of breast cancer patients through immunosensor based on silica-chitosan nanoplatform [Doi: 10.1016/j.talanta.2018.10.016]
Bioorganic Chemistry	Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers [Pubmed: 30665034]
Journal of?enzyme?inhibition and medicinal chemistry	Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile [Pubmed: 30919701]
Bioorganic Chemistry	Design and synthesis of new benzoxazole/benzothiazole-phthalimide hybrids as antitumor-apoptotic agents []
Bioorganic Chemistry	Synthesis and anticancer activity of bis-benzo [d][1, 3] dioxol-5-yl thiourea derivatives with molecular docking study [Pubmed: 31288134]
Oxidative Medicine and Cellular Longevity	Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters?… [Pubmed: 31737175]
Neoplasia	Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine [Pubmed: 33212364]
	Association between Serum Epidermal Growth Factor Receptor and Cyclooxygenase-2 Levels in Patients with Non-small Cell Carcinoma of Lung []
	Synthesis, EGFR-TK inhibition and anticancer activity of new quinoxaline derivatives []
IMMUNOLOGIC RESEARCH	Humoral immune response to epidermal growth factor receptor in lung cancer [33495907]
European Journal of Medicinal Chemistry	Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure¨Cactivity relationship and biological activity as potential antitumor and anticonvulsant agents [33545637]
Journal of Molecular Structure	Design, synthesis, antiproliferative evaluation, and molecular docking study of new quinoxaline derivatives as apoptotic inducers and EGFR inhibitors []
ACS Appl Mater Interfaces	Emitter–Quencher Pair of Single Atomic Co Sites and Monolayer Titanium Carbide MXenes for Luminol Chemiluminescent Reactions [34914377]
Bioorganic Chemistry	Discovery of new pyrimido [5, 4-c] quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies [Pubmed:35219045]

留言咨詢